California State Teachers Retirement System trimmed its stake in shares of Stryker Co. (NYSE:SYK) by 1.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 566,685 shares of the medical technology company’s stock after selling 7,962 shares during the period. California State Teachers Retirement System’s holdings in Stryker were worth $87,746,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of SYK. Truewealth LLC bought a new position in Stryker during the fourth quarter valued at $110,000. Sawyer & Company Inc bought a new position in Stryker during the fourth quarter valued at $125,000. Sit Investment Associates Inc. lifted its position in Stryker by 114.3% during the fourth quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock valued at $128,000 after purchasing an additional 440 shares during the last quarter. Virtue Capital Management LLC bought a new position in Stryker during the fourth quarter valued at $133,000. Finally, San Francisco Sentry Investment Group CA lifted its position in Stryker by 47.8% during the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock valued at $143,000 after purchasing an additional 325 shares during the last quarter. 75.71% of the stock is owned by institutional investors.
Several equities analysts have commented on SYK shares. Royal Bank of Canada reiterated a “buy” rating and set a $175.00 price objective on shares of Stryker in a research report on Tuesday, January 9th. ValuEngine upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. SunTrust Banks reiterated a “buy” rating and set a $161.00 price objective on shares of Stryker in a research report on Friday, November 17th. Piper Jaffray Companies reiterated a “buy” rating and set a $170.00 price objective on shares of Stryker in a research report on Wednesday, January 31st. Finally, Guggenheim reiterated a “buy” rating on shares of Stryker in a research report on Wednesday, January 31st. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company. Stryker presently has a consensus rating of “Buy” and a consensus price target of $163.85.
In related news, VP Yin C. Becker sold 23,221 shares of the firm’s stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $165.96, for a total value of $3,853,757.16. Following the transaction, the vice president now owns 10,499 shares of the company’s stock, valued at approximately $1,742,414.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Graham A. Mclean sold 2,984 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $160.53, for a total transaction of $479,021.52. Following the completion of the transaction, the insider now directly owns 9,100 shares in the company, valued at approximately $1,460,823. The disclosure for this sale can be found here. Insiders sold a total of 43,611 shares of company stock worth $7,178,719 in the last ninety days. 7.40% of the stock is currently owned by insiders.
Shares of Stryker Co. (SYK) opened at $167.89 on Tuesday. The stock has a market cap of $62,900.00, a PE ratio of 34.26, a PEG ratio of 2.39 and a beta of 0.70. The company has a quick ratio of 1.59, a current ratio of 2.29 and a debt-to-equity ratio of 0.66. Stryker Co. has a twelve month low of $129.29 and a twelve month high of $170.00.
Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.95 by $0.01. The firm had revenue of $3.47 billion during the quarter, compared to analyst estimates of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.56%. The business’s revenue was up 9.9% on a year-over-year basis. During the same quarter last year, the business earned $1.78 EPS. research analysts expect that Stryker Co. will post 7.12 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be paid a $0.47 dividend. This represents a $1.88 annualized dividend and a yield of 1.12%. The ex-dividend date is Wednesday, March 28th. Stryker’s dividend payout ratio is presently 38.37%.
ILLEGAL ACTIVITY WARNING: “Stryker Co. (SYK) Shares Sold by California State Teachers Retirement System” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://ledgergazette.com/2018/03/13/stryker-co-syk-shares-sold-by-california-state-teachers-retirement-system.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.